Thursday, May 16, 2013
EVA Airways Corp. announced yesterday that it will increase its flights to Paris and Vienna to four from the current three per week from May 16 and Sept. 2, respectively.
Wednesday, May 15, 2013
Quanta Computer (廣達), one of Taiwan's leading computer manufacturers, yesterday announced its first-quarter results, reporting net income of NT$4.454 billion, the lowest in 9 quarters.
Shares of Inventec Corp., one of Taiwan's leading notebook computer ODM services providers, moved higher Tuesday morning after the company reported better-than-expected first-quarter results, dealers said.
nese smartphone maker HTC Corp. is likely to improve its share in China with the latest version of its flagship smartphone, the HTC One, and could offer stiffer competition to market leader Samsung, a local analyst said Tuesday.
Japanese electronics maker Sharp Corp. named a new president Tuesday, reshuffling its top management to help restore profitability after reporting a record loss.
United Airlines said Monday that it would resume Boeing 787 Dreamliner flights this month after the troubled aircraft was modified to fix battery problems that led to a months-long grounding.
Matthew Winkler, editor-in-chief of Bloomberg News, apologized on Monday for allowing journalists “limited” access to sensitive data about how clients used Bloomberg terminals, saying it was “inexcusable,” but that important customer data had always been protected.
Japan's central bank on Tuesday became the latest organization to express concerns over the access journalists at Bloomberg News have had to potentially sensitive data.
Billionaire hedge fund investor Daniel Loeb on Tuesday called on Sony Corp. to spin off its lucrative entertainment arm, setting the stage for a clash between the activist fund and management at the Japanese electronics maker.
A subsidiary of India's largest pharmaceutical company has agreed to pay a record US$500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.